King Faisal Specialist Hospital & Research Centre (KFSHRC) has solidified its position as a global leader in healthcare innovation and transformation, leaving a strong mark at the 2024 NYC C3 Summit Davos of Healthcare. KFSHRC’s Deputy Chief Executive Officer, Dr. Björn Zoéga, was honored with the 2024 C3 Global Innovative Healthcare & Impact Transformation Award for the institution’s commitment to patient-centered care and technological advancements.
SOPHiA GENETICS and AstraZeneca have partnered to accelerate the deployment of the liquid biopsy test MSK-ACCESS® powered with SOPHiA DDMTM to 20 locations worldwide over the next 12 months. This partnership aims to expand access to liquid biopsy testing, particularly in underserved populations, and generate real-world data to advance cancer research.
FlyHospital, a medical travel platform, has launched in the US, connecting patients with top healthcare providers worldwide at significantly lower costs. Offering transparency, tailored medical travel plans, and complimentary services, FlyHospital aims to solve the accessibility issue in healthcare.
